Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

4,794 total articles

NRG: Undervalued Into Q1, Buy the Business, Watch the Chart

NRG: Undervalued Into Q1, Buy the Business, Watch the Chart

NRG offers a reasonable value proposition after the LS Power acquisition and a guidance raise. With market cap near $33.0B, free cash flow generation improving and EV/EBITDA around 13.2x, the stock looks attractively priced for a swing trade into Q1 results. That said, momentum indicators and moving averages point to technical risk — plan entries a…

Meta Platforms: Buy the AI-Driven Ads Recovery After a Capex Shock

Meta Platforms: Buy the AI-Driven Ads Recovery After a Capex Shock

Meta pulled back after an aggressive increase in AI capital guidance, but the underlying ad engine is improving via AI models that boost yield per ad. With a market cap around $1.54T, a trough in sentiment and supportive technicals, this trade seeks to buy the short-term fear and hold through improving monetization signals over the next 180 trading…

Ride the AI Compute Wave - Tactical Long on CoreWeave into Earnings

Ride the AI Compute Wave - Tactical Long on CoreWeave into Earnings

CoreWeave sits squarely in the AI compute supply chain with a $70.9B market cap, a massive revenue backlog, and rapid capacity expansion. The trade is a tactical long into earnings with defined risk controls: enter on strength or a measured pullback, stop beneath key technical support, and target a move toward the 52-week high if execution and back…

Exxon Mobil: Play the Oil Upswing with a Defined Risk Plan

Exxon Mobil: Play the Oil Upswing with a Defined Risk Plan

Exxon Mobil offers a tradeable long setup. The company’s strong free cash flow generation ($23.6B trailing), modest leverage (debt/equity ~0.27), and dividend yield near 2.7% provide a safety buffer while elevated oil prices and positive technical momentum create a favorable entry point. Our plan: enter at $152.19, target $170.00, stop $145.00 on a…

Abel's Early Moves and a Sharper Annual Meeting: A Tactical BRK.A Long

Abel's Early Moves and a Sharper Annual Meeting: A Tactical BRK.A Long

Greg Abel's early stewardship has already changed market dynamics at Berkshire Hathaway: a resumed buyback program, $234 million repurchase in Q1 and a $397 billion cash war chest have improved optionality. Valuation is reasonable by historical conglomerate standards (P/E ~15.3, P/B ~1.42) and the technicals show constructive momentum. This trade p…

Buy NBIS on the Eigen Pull: Play the AI Inference Bottleneck Reprieve

Buy NBIS on the Eigen Pull: Play the AI Inference Bottleneck Reprieve

Nebius (NBIS) is a neocloud infrastructure name that just closed a material valuation gap by agreeing to acquire Eigen AI for ~$643M. The deal strengthens Nebius' Token Factory and targets the AI inference cost curve, a pain point for enterprise adoption. The stock is expensive by earnings multiples but is trading on momentum and a credible path to…

LuxExperience: A Low-Priced Luxury Consolidator Worth a Long-Term Look

LuxExperience: A Low-Priced Luxury Consolidator Worth a Long-Term Look

LuxExperience (LUXE) trades at a rock-bottom P/E of ~2.0 and a P/B under 1, yet operates premium assets (Mytheresa, Net-A-Porter, Mr Porter, YOOX/THE OUTNET). The company's scale, margin leverage and recent technical setup make it an actionable long. This trade lays out an entry, stop and target for a long-term (180 trading days) position and walks…

Hut 8 Pre-Earnings: Positioning for an AI-Infra Re-Rate

Hut 8 Pre-Earnings: Positioning for an AI-Infra Re-Rate

Hut 8 shares have run hard into a new narrative: transforming large-scale power assets into AI and HPC data centers while carrying a sizable Bitcoin treasury. The stock is pricing growth aggressively, but a clear beat-and-extend on Q1 guidance could fuel another leg higher. This trade idea lays out an actionable long with entry, stop and target and…

CRH: Position for a Year of Outperformance After Q1 Beat

CRH: Position for a Year of Outperformance After Q1 Beat

CRH's diversified construction materials footprint, solid cash flow and recent Q1 momentum support a tactical long position. Valuation is reasonable at ~21x earnings with EV/EBITDA of 13.3 and ~ $3.0B in free cash flow. We recommend a long trade entry at $115.50, stop at $106.00 and target $132.00 on a long-term (180 trading days) horizon.

Blue Owl: Solid Fundamentals, Selective Buy — No Distress Found

Blue Owl: Solid Fundamentals, Selective Buy — No Distress Found

Blue Owl (OWL) looks oversold relative to cash-generation and dividend yield. Recent redemption chatter has dominated headlines, but underlying free cash flow and a $15.5B market cap argue against systemic distress. This is a tactical long with defined risk controls: entry $10.00, stop $8.50, target $15.00 over a long-term horizon (180 trading days…

Terns (TERN): Merger-Arb Play After Merck's $53 Bid — Strong Buy

Terns (TERN): Merger-Arb Play After Merck's $53 Bid — Strong Buy

Merck announced a $53 per-share all-cash acquisition of Terns Pharmaceuticals to add TERN-701 to its hematology pipeline. TERN trades at $52.96 — essentially at the offer level — creating a mid-term merger-arbitrage setup. The trade is a buy with a tight horizon toward a Q2 2026 close, but it comes with deal-execution risk after Merck trimmed a pri…

Buy BKR Ahead of a Cleaner Balance Sheet and Near-Term Order Momentum

Buy BKR Ahead of a Cleaner Balance Sheet and Near-Term Order Momentum

Baker Hughes is cycling through deliberate portfolio simplification, a meaningful order beat and large note issuance that together create a narrow window where closing a divestiture and redeploying cash should re-rate the stock. Enter at $69.90, stop $65.00, target $80.00 over a position trade (45 trading days) to capture accretion and sentiment up…

Why Popular's Rally Makes Sense - A Tactical Long Opportunity

Why Popular's Rally Makes Sense - A Tactical Long Opportunity

Popular, Inc. (BPOP) is trading near its 52-week high on a mix of steady fundamentals and improving technicals. With a market cap near $9.7B, P/E of ~11.6, ROE above 13%, and a 2.0% yield, the stock looks like a defensible long for a swing horizon (45 trading days). The trade plan is to buy at $149.35, place a stop at $138.00, and target $170.00, b…

Dolby: A Patient Long — Buy on the 2026 Pullback

Dolby: A Patient Long — Buy on the 2026 Pullback

Dolby dropped to the low $50s on heavy volume, creating an opportunity to add a durable licensing business with steady FCF, a 2.4% yield, and optional upside from faster adoption of Atmos and Vision. This trade is for patient investors who can tolerate a mid-single-digit drawdown while waiting up to 180 trading days for a recovery.